Pharmatest Services - Preclinical Contract Research

Pharmatest Services Ltd is a full-service bone biology CRO specialised in preclinical testing of new drug candidates both in vitro and in vivo. We provide cost-effective solutions for fast and high quality preclinical drug efficacy research.

Our unique in vitro bone cell pharmacodynamis assays, including osteoclast assays for antiresorptive compounds and osteoblast assays for anabolic compounds, are specifically designed for osteoporosis drug discovery. These bone cell assays are perfect tools for selecting the most potent drug candidates for further testing in our animal models. They also provide an ideal way to test new compounds against cancer-induced bone disease and metastases in a cost-effective in vitro setting.

Osteoporosis drug discovery - in vitro bone cell pharmacodynamis assays

These in vitro services are complimented by our wide selection of in vivo models, such as osteoporosis animal models; including rat ovariectomy and orchidectomy models, as well as a glucocorticoid-induced mouse osteoporosis model. The osteoporosis animal models can be performed according to FDA/EMEA guidelines, allowing the use of the results in the drug approval process.

Bone analysis services

Additionally, we offer animal models of cancer bone metastasis and osteoarthritis. We also provide bone analysis services, including BMD measurements, histology, histomorphometry, ash weight analysis, mechanical testing and biochemical markers. These methods are used routinely in our animal models, but they can also be performed as stand-alone services.

www.pharmatest.fi

Pharmatest Services Ltd
Itäinen Pitkäkatu 4 C, 5th floor
20520 Turku
FINLAND
Tel: +358 2 278 4700
Fax: +358 2 278 4710

Jussi Halleen, CEO, Scientific Director:
Tel: +358 2 278 4703
Mobile: +358 50 380 9551

Rami Käkönen, Chief Marketing Officer:
Tel: +358 2 278 4701
Mobile: +358 40 506 9944

Jukka Rissanen, COO, R&D Director:
Tel: +358 2 278 4702
Mobile: +358 50 522 0478

Mari Suominen, Research Director, cancer models:
Tel: +358 2 278 4704
Mobile: +358 40 7209603

Jukka Morko, Research Director, osteoporosis models:
Tel: +358 2 278 4705
Mobile: +358 40 7420028